AdvisorShares Psychedelics ETF (PSIL)

Assets	$20.62M
Expense Ratio	1.00%
PE Ratio	n/a
Shares Out	1.18M
Dividend (ttm)	$1.88
Dividend Yield	10.86%
Ex-Dividend Date	Dec 22, 2025
Payout Frequency	Quarterly
Payout Ratio	n/a

Volume	6,307
Open	17.66
Previous Close	17.54
Day's Range	17.07 - 17.66
52-Week Low	9.58
52-Week High	21.61
Beta	0.90
Holdings	30
Inception Date	Sep 15, 2021

About PSIL

Fund Home Page

The AdvisorShares Psychedelics ETF (PSIL) is an exchange-traded fund that mostly invests in health care equity. The fund is actively managed to provide exposure to the emerging global psychedelics industry. PSIL was launched on Sep 15, 2021 and is issued by AdvisorShares.

• Asset Class: Equity
• Category: Miscellaneous Sector
• Stock Exchange: NYSEARCA
• Ticker Symbol: PSIL
• ETF Provider: AdvisorShares

Top 10 Holdings

64.15% of assets

Name	Symbol	Weight
AtaiBeckley Inc.	ATAI	10.41%
Relmada Therapeutics, Inc.	RLMD	10.01%
Definium Therapeutics, Inc.	DFTX	9.14%
COMPASS Pathways plc	CMPS	6.91%
Cybin Inc.	HELP	4.85%
GH Research PLC	GHRS	4.73%
Neurocrine Biosciences, Inc.	NBIX	4.57%
Neuronetics, Inc.	STIM	4.54%
AbbVie Inc.	ABBV	4.51%
Bright Minds Biosciences Inc.	DRUG	4.50%

Dividend History

Ex-Dividend	Amount	Pay Date
Dec 22, 2025	$1.6839	Dec 29, 2025
Sep 22, 2025	$0.0201	Sep 29, 2025
Jun 23, 2025	$0.01191	Jun 27, 2025
Mar 21, 2025	$0.16343	Mar 28, 2025
Dec 23, 2024	$0.0548	Dec 30, 2024
Sep 23, 2024	$0.1087	Sep 30, 2024

Performance

PSIL had a total return of 78.38% in the past year, including dividends. Since the fund's inception, the average annual return has been -29.76%.